Triazinone and diazinone derivatives useful as Hsp90 inhibitors

Details for Australian Patent Application No. 2008232354 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Przewloka, Teresa; Song, Minghu; Qin, Shuzhen; Foley, Kevin; Ying, Weiwen; Lee, Chi-Wan; Du, Zhenjian; Zhou, Dan

Agent Davies Collison Cave

Pub. Number AU-B-2008232354

PCT Pub. Number WO2008/118391

Priority 60/920,327 27.03.07 US

Filing date 24 March 2008

Wipo publication date 2 October 2008

Acceptance publication date 28 June 2012

International Classifications

C07D 239/10 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/4168

A61K 31/4196 - 1,2,4-Triazoles

A61P 35/00 Antineoplastic agents

C07D 249/12 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/118391 Priority application(s): WO2008/118391

28 June 2012 Application Accepted

  Published as AU-B-2008232354

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008232360-Fluid collection and disposal system having internchangeable collection and other features and methods relating thereof

2008232341-Amino5-[4-(difluoromethoxy)phenyl]-5-phenyli midazolone compounds for the inhibition of beta-secretase